The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
An Echocardiographic Study of Valvular Heart Disease Associated with Systemic Lupus Erythematosus
Abstract
BACKGROUND: Valvular heart disease is the most important cardiac manifestation of systemic lupus erythematosus. We performed a study to determine the relation of valvular disease to other clinical features of lupus, whether or not the valve disease progresses, and the associated morbidity and mortality. METHODS: We performed transesophageal echocardiography and rheumatologic evaluations in 69 patients with systemic lupus erythematosus. The echocardiographic findings were compared with those in 56 healthy volunteers. Fifty-eight patients (84 percent) had second evaluations a mean (+/-SD) period of 29 +/- 13 months later. The patients and controls were followed for 57 months. RESULTS: Valvular abnormalities were common on the initial and the follow-up echocardiograms (in 61 and 53 percent of the patients, respectively). Valvular thickening was the predominant finding initially and on follow-up (in 51 and 52 percent of the patients, respectively), followed by vegetations (in 43 and 34 percent), valvular regurgitation (in 25 and 28 percent), and stenosis (in 4 and 3 percent). Valvular abnormalities frequently resolved, appeared for the first time, or persisted but changed in appearance or size between the two studies. Mild or moderate valvular regurgitation did not progress to become severe, and new stenoses did not develop. Neither the presence of valvular disease nor changes in the echocardiographic findings were temporally related to the duration, activity, or severity of lupus or to its treatment. The combined incidence of stroke, peripheral embolism, heart failure, infective endocarditis, and the need for valve replacement was 22 percent in the patients with valvular disease, but only 8 percent in those without it. A total of seven patients died during follow-up, in most cases as a result of valvular disease. Valvular abnormalities and complications were uncommon in the controls (occurring in 9 and 2 percent, respectively). CONCLUSIONS: Valvular heart disease is common in patients with systemic lupus erythematosus, frequently changes over time, appears to be temporally unrelated to other clinical features of lupus, and is associated with substantial morbidity and mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE NATURAL HISTORY OF SYSTEMIC LUPUS ERYTHEMATOSUS BY PROSPECTIVE ANALYSIS
ESTES, D., & CHRISTIAN, C. L. (1971) · Medicine · doi:10.1097/00005792-197103000-00001 · Cited by 936
Evaluation of aortic insufficiency by Doppler color flow mapping
Perry, G. J., Helmcke, F., Nanda, N. C., Byard, C., & Soto, B. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80254-1 · Cited by 882
SEWARD, J. B., KHANDHERIA, B. K., OH, J. K., ABEL, M. D., HUGHES, R. W., EDWARDS, W. D., NICHOLS, B. A., FREEMAN, W. K., & TAJIK, A. J. (1988) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65529-3 · Cited by 791
The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy
Bulkley, B. H., & Roberts, W. C. (1975) · The American Journal of Medicine · doi:10.1016/0002-9343(75)90575-6 · Cited by 670
A HITHERTO UNDESCRIBED FORM OF VALVULAR AND MURAL ENDOCARDITIS
LIBMAN, E. (1924) · Archives of Internal Medicine · doi:10.1001/archinte.1924.00110300044002 · Cited by 557
Currie, P. J., Seward, J. B., Reeder, G. S., Vlietstra, R. E., Bresnahan, D. R., Bresnahan, J. F., Smith, H. C., Hagler, D. J., & Tajik, A. J. (1985) · Circulation · doi:10.1161/01.cir.71.6.1162 · Cited by 520
Age and the Cardiovascular System
Epstein, F. H., & Wei, J. Y. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212103272408 · Cited by 483
Heart Valve Involvement (Libman-Sacks Endocarditis) in the Antiphospholipid Syndrome
Hojnik, M., George, J., Ziporen, L., & Shoenfeld, Y. (1996) · Circulation · doi:10.1161/01.cir.93.8.1579 · Cited by 443
Khamashta, M. A., Cervera, R., Asherson, R. A., Hughes, G. R. V., Coltart, D. J., Font, J., Ingelmo, M., Paré, C., Gil, A., Vázquez, J. J., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)91373-i · Cited by 320
Galve, E., Candell-Riera, J., Pigrau, C., Permanyer-Miralda, G., Garcia-Del-Castillo, H., & Soler-Soler, J. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809293191302 · Cited by 239
Cited by
Ward, M. M. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199902)42:2<338::aid-anr17>3.0.co;2-u · Cited by 529
Guidelines for the Use of Echocardiography in the Evaluation of a Cardiac Source of Embolism
Saric, M., Armour, A. C., Arnaout, M. S., Chaudhry, F. A., Grimm, R. A., Kronzon, I., Landeck, B. F., Maganti, K., Michelena, H. I., & Tolstrup, K. (2016) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2015.09.011 · Cited by 427
Cardiac involvement in systemic lupus erythematosus
Doria, A., Iaccarino, L., Sarzi-Puttini, P., Atzeni, F., Turriel, M., & Petri, M. (2005) · Lupus · doi:10.1191/0961203305lu2200oa · Cited by 396
Inflammation and Infection in Clinical Stroke
Emsley, H. C. A., & Tyrrell, P. J. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200212000-00001 · Cited by 276
Chang, J. C., Xiao, R., Mercer-Rosa, L., Knight, A. M., & Weiss, P. F. (2018) · Lupus · doi:10.1177/0961203318804889 · Cited by 67
Metadata
- Authors
- Roldan, C. A., Shively, B. K., & Crawford, M. H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1996-11-07
- Volume
- 335
- Issue
- 19
- Pages
- 1424-1430
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2322262491
- Cited by
- 330
- References
- 25
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Echocardiographic Study of Valvular Heart Disease Associated with Systemic Lupus Erythematosus. https://app.cochat.ai/papers/10.1056/nejm199611073351903
- The paper
- Roldan, C. A., Shively, B. K., & Crawford, M. H. (1996). An Echocardiographic Study of Valvular Heart Disease Associated with Systemic Lupus Erythematosus. New England Journal of Medicine. https://doi.org/10.1056/nejm199611073351903
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.